| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/12/2008 | US7329484 Preparing a substrate by exposing the sample to at least two combinations of adsorbent and an eluant; identifying by desorption spectrometry at least one selectivity condition under which the analyte is retained; and immobilizing an adsorbent of an identified selectivity condition on the substrate |
| 02/12/2008 | US7329402 Methods of imaging and treatment |
| 02/12/2008 | US7329401 Cyclooxygenase-2 selective agents useful as imaging probes and related methods |
| 02/12/2008 | CA2274132C Macrocyclic metal complex carboxylic acids, use and method for the production thereof |
| 02/12/2008 | CA2142302C Method of improving fat saturation during mri |
| 02/07/2008 | WO2008016762A1 Fluorogenic protein kinase substrates |
| 02/07/2008 | WO2008016139A1 Fluorescent oleamide derivative and use thereof |
| 02/07/2008 | WO2008015415A2 Asymmetric fluoro-substituted polymethine dyes |
| 02/07/2008 | WO2008015012A1 Microbubbles as drug delivery device |
| 02/07/2008 | WO2007122226A3 Patch and uses thereof |
| 02/07/2008 | WO2006136564A9 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 02/07/2008 | US20080031883 Condition-dependent, multiple target delivery system |
| 02/07/2008 | US20080031871 Memory and learning impairments associated with disruption of Ephrin receptor A6 (EphA6) gene |
| 02/07/2008 | US20080031822 Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine |
| 02/07/2008 | US20080031821 USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION |
| 02/07/2008 | US20080031820 Swine multipotent adult progenitor cells |
| 02/07/2008 | US20080031819 Compositions and Methods that Enhance Articular Cartilage Repair |
| 02/07/2008 | US20080031818 Use of Modulators of a Novel Form of Muscle Selective Calcineurin Interacting Protein (Mcip-1-38) as a Treatment for Cardiovascular Diseases |
| 02/07/2008 | US20080031816 Methods and compositions for identifying biomarkers |
| 02/07/2008 | US20080031815 Pet imaging of vascular endothelial growth factor receptor (VEGFR), compositions for VEGF cancer imaging, and methods of VEGF cancer imaging |
| 02/07/2008 | US20080031814 Non-allergenic ingredients and food products |
| 02/07/2008 | CA2695147A1 Dyes and precursors and conjugates thereof |
| 02/07/2008 | CA2695117A1 Dyes and precursors and conjugates thereof |
| 02/06/2008 | EP1884232A1 Method of producing liposomes containing gas enclosed therein |
| 02/06/2008 | EP1883428A2 Contrast agents |
| 02/06/2008 | EP1883343A2 Biomarkers sensing |
| 02/06/2008 | CN100366310C Regulation of eating habits |
| 02/05/2008 | US7326769 Subjecting an extract of a group 1, 2, 3, 10, and/or 13 Phleum pretense to hydrophobic interaction chromatography, followed by gel filtration and optionally followed by cation exchanger chromatography; facilitate improved diagnosis of pollen allergies |
| 02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 02/05/2008 | US7326529 Using cancer specific genes |
| 02/05/2008 | US7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/05/2008 | US7326402 Method of diagnosing, monitoring, staging, imaging and treating cancer |
| 02/05/2008 | CA2294040C Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 02/05/2008 | CA2165039C Cyclohexapeptides and their mixtures, a process for preparing them, and their use |
| 01/31/2008 | WO2008014393A2 Non-invasive in-vivo imaging of mechanoreceptors in skin using confocal microscopy |
| 01/31/2008 | WO2008014216A1 Method for treating ocular cancer |
| 01/31/2008 | WO2008013302A1 Jelly for endoscopic swallowing evaluation |
| 01/31/2008 | WO2008012785A2 A probe for cellular oxygen |
| 01/31/2008 | WO2008012102A2 Radiodense conjugate |
| 01/31/2008 | WO2007129311A3 Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct |
| 01/31/2008 | WO2007120311A3 Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics |
| 01/31/2008 | WO2007066115B1 Novel imaging agents for fibrosis |
| 01/31/2008 | WO2007030802A3 Targeted contrast agents and methods for targeting contrast agents |
| 01/31/2008 | US20080027135 Methods For Identifying Chemical Modulators Of Ras Superfamily Gptase Activity |
| 01/31/2008 | US20080025918 Invisible light fluorescent platelets for intraoperative detection of vascular thrombosis |
| 01/31/2008 | US20080025917 Methods for modulating formation and progression of cellulite |
| 01/31/2008 | US20080025916 Tailored Treatment Suitable for Different Forms of Mastocytosis |
| 01/31/2008 | DE102006035577A1 Röntgendichtes Konjugat Radiopaque conjugate |
| 01/30/2008 | EP1881852A2 Mri contrast agents comprising cest active paramagnetic complex |
| 01/30/2008 | EP1881851A1 Effect of substances on sexual function |
| 01/30/2008 | EP0941125B1 Methods for regulating angiogenesis |
| 01/30/2008 | CN101115507A Fluorescent contrast agents |
| 01/30/2008 | CN101112304A Method for detecting the skin irritation intensity caused by skin care products and arrangement thereof |
| 01/30/2008 | CN100365041C Polyoxyethylene ligand containing coupler and its synthesis process |
| 01/29/2008 | CA2271735C Magnetic resonance blood pool agents |
| 01/29/2008 | CA2147469C Compaction assay for assessment of respiratory disease therapy |
| 01/24/2008 | WO2008011430A2 Compositions and methods for the treatment of diseases associated with aberrant cilia assembly and regulation |
| 01/24/2008 | WO2008011047A2 Amine dendrimers |
| 01/24/2008 | WO2008011017A2 Methods and compositions for treating vascular disease |
| 01/24/2008 | WO2008011008A1 Bioluminescent imaging of trail induced apoptosis |
| 01/24/2008 | WO2007110867A3 Implantable sensor |
| 01/24/2008 | WO2006099019A8 Methods and composition related to in vivo imaging of gene expression |
| 01/24/2008 | WO2006066008A3 Device and methods for identifying and treating aspirin non-responsive patients |
| 01/24/2008 | US20080020461 Kinesin-like proteins and methods of use |
| 01/24/2008 | US20080019922 Quinazoline derivatives, their preparation, their use, and medicaments comprising them |
| 01/24/2008 | US20080019921 Uniform fluorescent microsphere with hydrophobic surfaces |
| 01/24/2008 | US20080019920 Neurotransmitter Sensors and Methods of Using the Same |
| 01/24/2008 | US20080019919 Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium |
| 01/24/2008 | US20080019918 Medicinal Preparation |
| 01/24/2008 | US20080019916 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 01/24/2008 | US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis |
| 01/24/2008 | US20080019913 Enkepahlin analogs with improved bioavailability |
| 01/24/2008 | US20080019912 Glycoprotein 5 (GP5) and M protein of PRRSV linked by a disulfide bond gives rise to protective antigenic determinant (PAD polypeptide) that is used provide protection PRRSV; immunizing pigs |
| 01/24/2008 | US20080019911 Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4 |
| 01/24/2008 | US20080019910 Cancer Treatment and Cancer Treatment Efficacy Prediction by Blocking and Detecting Protease Inhibitors |
| 01/24/2008 | US20080019909 Modulation of Programmed Necrosis |
| 01/24/2008 | US20080019908 Novel amphiphilic substance, and drug delivery system and molecular imaging system using the same |
| 01/24/2008 | US20080019907 with affinity for an abnormally expressed biological target associated with atherosclerotic plaque; use in diagnosis, surgical guidance |
| 01/24/2008 | US20080019904 System For Manufacturing Micro-Sheres |
| 01/24/2008 | US20080018899 Method and apparatus for 3-d imaging of internal light sources |
| 01/23/2008 | EP1880737A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 01/23/2008 | EP1880330A1 Systems and methods for managing information relating to medical fluids and containers therefor |
| 01/23/2008 | EP1879627A2 Methods for measuring cholesterol metabolism and transport |
| 01/23/2008 | EP1879625A2 Mri contrast agents endowed with concentration independent responsiveness |
| 01/23/2008 | EP1879554A2 Compositions and methods using microspheres and non-ionic contrast agents |
| 01/23/2008 | EP1768705A4 Method for detecting alzheimer's disease and other forms of dementia, and measuring their progression |
| 01/23/2008 | EP1682113B1 Inhibitor imaging agents |
| 01/23/2008 | EP1401267A4 Animal model for allergy |
| 01/22/2008 | US7321045 Vitronectin receptor antagonist pharmaceuticals |
| 01/22/2008 | US7320785 Compositions and methods for modulation of DARPP-32 phosphorylation |
| 01/22/2008 | US7320784 Metal support surface, conjugate releasably bound to the support surface, the conjugate comprising a ligand and a targeting molecule;wherein the conjugate coordinates with a complex-forming metal ion so that labeled conjugate is released; radiotherapy and as imaging agents in medical diagnostics |
| 01/22/2008 | CA2185114C Recombinant humanized anti-lewis y antibodies |
| 01/17/2008 | WO2008008786A2 Pre- and intra- operative imaging of bladder cancer |
| 01/17/2008 | WO2008008075A2 Magnetic resonance imaging (mri) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization |
| 01/17/2008 | WO2008007290A2 Core-shell nanoparticles for thearapy and imaging purposes |
| 01/17/2008 | WO2008006658A1 Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| 01/17/2008 | WO2007127151A3 Non-human model of autoimmune disease |
| 01/17/2008 | WO2007102933A8 Composition for ultrasound therapy and pharmaceutical liquid composition containing the same |
| 01/17/2008 | WO2007038346A3 Multiphoton in vivo flow cytometry method and device |
| 01/17/2008 | US20080014150 Compositions and method for treating precancerous virus infection and prevention of cancer |